本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bioventus Inc.

7.27
-0.1700-2.28%
盘后7.270.00000.00%18:18 EDT
成交量:112.12万
成交额:812.70万
市值:6.01亿
市盈率:262.53
高:7.44
开:7.44
低:7.09
收:7.44
52周最高:14.38
52周最低:5.81
股本:8,267.90万
流通股本:4,322.04万
量比:2.28
换手率:2.59%
股息:- -
股息率:- -
每股收益(TTM):0.0277
每股收益(LYR):-0.5196
净资产收益率:1.39%
总资产收益率:3.64%
市净率:3.73
市盈率(LYR):-13.99

数据加载中...

2024/11/01

SEC问询函

Form CORRESP - Correspondence
2024/10/04

重要事件披露

Form 8-K - Current report
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/19

重要事件披露

Form 8-K - Current report
2024/07/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/21

重要事件披露

Form 8-K - Current report
2024/06/17

重要事件披露

Form 8-K - Current report
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]